Clin2
NCT07168018Possibly a fitNot yet recruiting

Testing a new rabies vaccine given with the standard vaccine

Rabies

Part of Infections clinical trials.

This trial tests if a new experimental rabies vaccine (ChAdOx2 RabG) can be safely given together with the regular rabies vaccine. Healthy adults aged 18–45 may join to help see if the combination works and is safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are generally healthy, with a BMI between 18 and 30.
  • You have not received any rabies vaccine before.
  • You are not pregnant, breastfeeding, or planning pregnancy (for women).
  • You do not have a weakened immune system, serious allergies, or a bleeding disorder.
  • You have not had certain vaccines in the past month or an adenovirus vaccine in the past 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07345208Not yet recruiting· Phase 2/Phase 3
Study comparing two ways to give rabies vaccine

This trial tests if a rabies vaccine given as a small injection into the skin works as well as the standard shot into muscle. It may mean fewer side effects and use less vaccine.

Mymensingh
NCT07055880Not yet recruiting· Phase 2
Different doses of a rabies vaccine test

This study tests different doses of an experimental rabies vaccine to see which dose works best and is safest. It is for healthy adults who have never had a rabies shot before and are not at recent risk of rabies exposure.

Karachi
NCT07055295Not yet recruiting· Phase 3
Rabies vaccine safety and immune response study

This trial tests a new rabies vaccine to see how well it works and if it is safe for people who have not been exposed to rabies. It may be a good option if you want protection before potential exposure.

Rawalpindi
NCT07028801Not yet recruiting· Phase 3
Testing a new rabies vaccine for people

This trial tests a new freeze-dried rabies vaccine made from human cells. It is for people who may need protection against rabies after a possible exposure, and the study will compare it to standard rabies vaccines.

Zhengzhou, Henan
NCT07021703Recruiting· Phase 1
Rabies vaccine trial for people aged 10 to 60

This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.

Zhengzhou, Henan
NCT07445815Not yet recruiting· Phase 2
Testing a new rabies antibody in healthy adults

This trial tests a new lab-made antibody to prevent rabies after exposure. It is for healthy volunteers who have not gotten a rabies vaccine or been exposed to rabies before.

Lanzhou, Gansu

Hear when a new Rabies trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.